摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苯并呋喃-5-甲醛 | 10035-16-2

中文名称
1-苯并呋喃-5-甲醛
中文别名
苯并呋喃-5-甲醛
英文名称
benzofuran-5-carbaldehyde
英文别名
1-benzofuran-5-carbaldehyde;benzofuran-5-carboxaldehyde;benzo[b]furan-5-carboxaldehyde
1-苯并呋喃-5-甲醛化学式
CAS
10035-16-2
化学式
C9H6O2
mdl
MFCD03411182
分子量
146.145
InChiKey
LLLBDLDNTMMZHL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    50.5
  • 沸点:
    70-74°C 0,15mm
  • 密度:
    1.238±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    30.2
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2932999099
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    温度:2-8℃,保持惰性气体氛围。

SDS

SDS:50a25eb5c64659fd0c31990255b3655a
查看
Name: 1-Benzofuran-5-carbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS: 10035-16-2
Section 1 - Chemical Product MSDS Name:1-Benzofuran-5-carbaldehyde 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
10035-16-2 1-Benzofuran-5-carbaldehyde 97% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Air sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 10035-16-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 70 - 74 deg C
Freezing/Melting Point: 50.5 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H6O2
Molecular Weight: 146.14

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to air.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 10035-16-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Benzofuran-5-carbaldehyde - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 10035-16-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 10035-16-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10035-16-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    1-苯并呋喃-5-甲醛硫酸氢铵 、 sodium carbonate 、 sulfur 作用下, 以 二甲基亚砜 为溶剂, 反应 10.0h, 以96%的产率得到1-苯并呋喃-5-甲腈
    参考文献:
    名称:
    一种硫粉促进的无机铵为氮源的芳香醛转化为芳香腈的方法
    摘要:
    本发明公开了一种芳香醛转化为芳香腈的方法。该方法是硫粉促进的无机铵为氮源的芳香醛一锅反应高收率的转化为芳香腈。该方法具有不需要金属参与,不需要使用强氧化物,且反应对空气兼容、易于扩增至克级规模等优点,克服了现有技术中反应条件苛刻,如需要使用昂贵的金属试剂,或需使用有毒试剂,操作复杂,官能团相容性低等问题。
    公开号:
    CN111606823A
  • 作为产物:
    描述:
    2,3-二氢苯并呋喃-5-甲醛N-溴代丁二酰亚胺(NBS)偶氮二异丁腈 作用下, 以 氯苯 为溶剂, 反应 1.0h, 以83%的产率得到1-苯并呋喃-5-甲醛
    参考文献:
    名称:
    Substituted Pyran Derivatives
    摘要:
    提供了在单胺转运系统上表现出强效活性的某些3,6-二取代和2,4,5-三取代吡喃衍生物。这些3,6和2,4,5吡喃物在探究它们与单胺转运体系的结合效应以及与影响中枢神经系统的各种疾病之间的关系,或作为治疗涉及单胺转运和相关系统的各种中枢神经系统相关疾病的方法中是有用的。
    公开号:
    US20140309427A1
  • 作为试剂:
    描述:
    参考文献:
    名称:
    J. Med. Chem. 1999, 42, 5311-5324
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Transfer Hydrodeuteration of Aryl Alkenes with Quantitative Isotopomer Purity Analysis by Molecular Rotational Resonance Spectroscopy
    作者:Zoua Pa Vang、Albert Reyes、Reilly E. Sonstrom、Martin S. Holdren、Samantha E. Sloane、Isabella Y. Alansari、Justin L. Neill、Brooks H. Pate、Joseph R. Clark
    DOI:10.1021/jacs.1c00884
    日期:2021.5.26
    A copper-catalyzed alkene transfer hydrodeuteration reaction that selectively incorporates one hydrogen and one deuterium atom across an aryl alkene is described. The transfer hydrodeuteration protocol is selective across a variety of internal and terminal alkenes and is also demonstrated on an alkene-containing complex natural product analog. Beyond using 1H, 2H, and 13C NMR analysis to measure reaction
    描述了一种铜催化的烯烃转移加氢氘化反应,该反应选择性地将一个氢和一个氘原子结合到芳基烯烃上。转移加氢氘化协议对各种内部和末端烯烃具有选择性,并且还在含烯烃的复杂天然产物类似物上得到了证明。除了使用1 H、2 H 和13C NMR 分析测量反应选择性,六转移氢化氘化产物通过分子旋转共振 (MRR) 光谱分析。通过与高通量样品分析兼容的测量方法,进一步探索了 MRR 光谱在氘化学中同位素杂质分析中的应用。在第一步中,使用宽带啁啾脉冲傅立叶变换微波光谱仪分析反应化学中所有同位素变体的 MRR 光谱特征。有了签名,就可以创建测量脚本,使用商用腔增强 MRR 光谱仪对样品成分进行定量分析。使用该仪器的样品消耗量低于 10 毫克,分析时间约为 10 分钟 - 与宽带 MRR 光谱相比,两者都代表了数量级的减少。迄今为止,这些测量代表了转移加氢氘化反应中选择性的最精确的光谱测定,并确认在这种温和的协议下可以实现
  • Efficient Water Reduction with sp<sup>3</sup> -sp<sup>3</sup> Diboron(4) Compounds: Application to Hydrogenations, H-D Exchange Reactions, and Carbonyl Reductions
    作者:Mathias Flinker、Hongfei Yin、René W. Juhl、Espen Z. Eikeland、Jacob Overgaard、Dennis U. Nielsen、Troels Skrydstrup
    DOI:10.1002/anie.201709685
    日期:2017.12.11
    demonstrated by conducting a series of selective reductions of alkynes and alkenes, and hydrogen–deuterium exchange reactions using two‐chamber reactors. Finally, as the water reduction reaction generates an intermediate borohydride species, a range of aldehydes and ketones were reduced by using water as the hydride source.
    合成了一系列结晶的sp 3 -sp 3 diboron(4)化合物,它们显示出促进形成二氢的水的简便还原。通过对乙炔和烯烃进行一系列的选择性还原,以及使用两室反应器进行氢-氘交换反应,证明了这些二硼作为简单有效的二氢和二氘源的应用。最后,由于水还原反应生成了中间的硼氢化物,通过使用水作为氢化物源,可以还原一系列醛和酮。
  • Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
    申请人:Lynch K. John
    公开号:US20050209274A1
    公开(公告)日:2005-09-22
    The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    本发明涉及式(I)的化合物,通过对抗黑素浓集激素(MCH)的作用,通过对抗黑素浓集激素受体,有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
  • 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency
    作者:Alan D. Borthwick、Dave E. Davies、Anne M. Exall、Richard J. D. Hatley、Jennifer A. Hughes、Wendy R. Irving、David G. Livermore、Steve L. Sollis、Fabrizio Nerozzi、Klara L. Valko、Michael J. Allen、Marion Perren、Shalia S. Shabbir、Patrick M. Woollard、Mark A. Price
    DOI:10.1021/jm060073e
    日期:2006.7.1
    A short, efficient, and highly stereoselective synthesis of a series of (3R,6R,7R)-2,5-diketopiperazine oxytocin antagonists and their pharmacokinetics in rat and dog is described. Prediction of the estimated human oral absorption (EHOA) using measured lipophilicity (CHI log D) and calculated size (cMR) has allowed us to rank various 2,5-diketopiperazine templates and enabled us to focus effort on
    描述了一系列(3R,6R,7R)-2,5-二酮哌嗪催产素拮抗剂的短而有效且高度立体选择性的合成及其在大鼠和狗中的药代动力学。使用测得的亲脂性(CHI log D)和计算的大小(cMR)来预测估计的人类口服吸收(EHOA),使我们能够对各种2,5-二酮哌嗪模板进行排名,并使我们能够将精力集中在那些模板上的机会最大。人类的生物利用度高。这迅速导致2',4'-二氟苯基-二甲基酰胺25和苯并呋喃4在大鼠和狗中具有高水平的效力(pK(i))和良好的生物利用度。体内二甲酰胺25的效力比4强(> 20倍),并且对血管加压素受体的选择性很高,hV1a / hV1b大于10,000,hV2大约为500。
  • Studies on Cognitive Enhancing Agents. III. Antiamnestic and Antihypoxic Activities of a Series of l-Bicycloaryl-2-(.OMEGA.-aminoalkoxy)ethanols.
    作者:Satoshi ONO、Tetsuo YAMAFUJI、Hisaaki CHAKI、Hajime MORITA、Yozo TODO、Naomi OKADA、Mutsuko MAEKAWA、Kazunori KITAMURA、Masaru TAI、Hirokazu NARITA
    DOI:10.1248/cpb.43.1492
    日期:——
    2-(2-Aminoethoxy)-1-hydroxyethyl derivatives of bicyclic arenes) naphthalene, thianaphthene, benzofuran, and indole) were prepared and screened for antiamnestic (AA) and antihypoxic (AH) activities which were evaluated by measuring the reversing potency in electroconvulsion-induced amnesia and the protective effect against hypoxia, respectively, in mice. Compound 3o, 1-(benzo[b]thiophen-5-yl)-2-(2-diethylaminoethoxy)ethanol, showed the best AA and AH activity profile, being superior to our prototype compound, 2-(2-dimethylaminoethoxy)-1-phenylethanol (1). Elongation of the ethylene linkage in the side chain of 3o to 3- and 4-carbon moiethies brought about a significant decrease in AH activity. Compound 3o was further investigated for its protective effect against Co2-induced memory impairment and for acute toxicity in mice. It is ten-fold more potent than tacrine in the amnesia-reversal assay and is considerably less toxic than tacrine.
    双环芳烃(萘、噻吊、苯并呋喃和吲哚)的2-(2-氨基乙氧基)-1-羟乙基衍生物被制备并筛选出具有抗遗忘(AA)和抗缺氧(AH)活性的化合物。这些活性通过测定逆转电休克诱导的遗忘和保护小鼠免受缺氧影响的效力来评估。化合物3o,1-(苯并[b]噻吩-5-基)-2-(2-二乙基氨基乙氧基)乙醇,显示出最佳的AA和AH活性特征,优于我们的原型化合物,2-(2-二甲基氨基乙氧基)-1-苯乙醇(1)。在3o的侧链中延长乙烯链接到3-和4-碳单元,显著降低了AH活性。化合物3o进一步研究了其对Co2诱导记忆障碍的保护作用和在小鼠中的急性毒性。在逆转遗忘试验中,其效力是他克林的十倍,并且毒性远低于他克林。
查看更多

同类化合物

顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基- 苯甲基(1-{(2-amino-2-methylpropanoyl)[(2S)-2-aminopropanoyl]amino}-2-methyl-1-oxopropan-2-yl)甲基氨基甲酸酯(non-preferredname) 苯并呋喃并[3,2-d]嘧啶-2,4(1H,3H)-二酮 苯并呋喃并[3,2-D]嘧啶-4(1H)-酮 苯并呋喃并[2,3-d]哒嗪-4(3H)-酮 苯并呋喃并(3,2-c)吡啶,1,2,3,4-四氢-2-(2-(二甲氨基)乙基)-,二盐酸 苯并呋喃与1H-茚的聚合物 苯并呋喃[3,2-b]吡咯-2-羧酸 苯并呋喃-7-羧酸 苯并呋喃-7-硼酸频那醇酯 苯并呋喃-7-甲腈